Basildon (UK), 4 May 2021 – Atnahs, the original medicines specialist backed by PE investor Triton Partners,...
More informationBasildon (UK), 22 March 2021 – Atnahs has appointed Felipe Florez to the position of Chief Financial...
More informationBasildon (UK), 1 December 2020 – Atnahs (“Atnahs”), has acquired the commercial rights for Valium® (Diazepam) in...
More informationBasildon (UK), 19 March 2020 – On 11 March 2020 the World Health Organization (WHO) declared...
More informationBasildon (UK) / Basle (Switzerland), 19 March 2020 – Atnahs (“Atnahs”), a Triton Fund V portfolio company,...
More informationBasildon (UK), 6 February 2020 – Atnahs has bought Takeda out of a license agreement for...
More informationBasildon / Cambridge (UK), 27 January 2020 – Atnahs, a Triton Fund V portfolio company, has signed...
More informationFrankfurt (Germany), Basildon (United Kingdom), August 8, 2019 – Funds advised by Triton have successfully completed...
More informationBasildon, UK. Atnahs Pharma UK Limited (“Atnahs”) is pleased to announce the acquisition of Famvir® from...
More information